tryptophan has been researched along with Adenocarcinoma Of Kidney in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 6 (60.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bossé, D; Braun, D; Bullock, K; Choueiri, TK; Clish, CB; Freeman, GJ; Garraway, LA; Giannakis, M; Gopal, S; Gurjao, C; Horak, C; Jin, C; Lalani, AA; Li, H; McDermott, DF; Schreiber, SL; Sellers, WR; Shukla, SA; Signoretti, S; Stephen Hodi, F; Van Allen, EM; Wind-Rotolo, M | 1 |
| Wettersten, HI | 1 |
| Fukaya, K; Ichino, M; Maeda, Y; Muto, Y; Nagakawa, T; Nukaya, T; Saito, K; Sasaki, H; Shiogama, K; Shiroki, R; Sumitomo, M; Takahara, K; Takenaka, M; Yamamoto, Y; Zennami, K | 1 |
| Kister, D; Kruger, WD; Lee, HO; Uzzo, RG | 1 |
| Weiss, RH | 1 |
| Abu Aboud, O; Anderson, K; Berryhill, G; Chen, CH; Graef, A; Hovey, RC; Kim, J; Modiano, JF; Sarver, AL; Stewart, B; Trott, JF; Uzal, F; Weiss, RH; Wettersten, H | 1 |
| Abu Aboud, O; Alexander, DC; Evans, C; Ganti, S; Kim, K; Osier, MV; Taylor, SL; Weiss, RH; Yang, J | 1 |
| Beaune, P; Bertho, G; Fougeray, S; Mami, I; Pallet, N; Thervet, E | 1 |
| BARKIN, M; KERR, WK; MENCZYK, Z; TODD, IA | 1 |
| Buchner, A; Castro, M; Eder, M; Hatz, RA; Hofstetter, A; Kammerer, R; Popp, T; Riesenberg, R; Spring, O; Stief, CG; Takikawa, O; Weiler, C; Zimmermann, W | 1 |
2 review(s) available for tryptophan and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Reprogramming of Metabolism in Kidney Cancer.
Topics: Arachidonic Acid; Carcinoma, Renal Cell; Cellular Reprogramming; Citric Acid Cycle; Cytochrome P-450 Enzyme System; Fatty Acids; Glucose; Glucose Transport Proteins, Facilitative; Glycerophospholipids; Glycolysis; Humans; Kidney; Kidney Neoplasms; Metabolic Networks and Pathways; Oxidative Phosphorylation; Pentose Phosphate Pathway; Sodium-Glucose Transport Proteins; Tryptophan; Tumor Microenvironment | 2020 |
Metabolomics and Metabolic Reprogramming in Kidney Cancer.
Topics: Adaptation, Physiological; Arginine; Carcinoma, Renal Cell; Fatty Acids; Glutamine; Glycolysis; Humans; Kidney Neoplasms; Lipids; Metabolic Networks and Pathways; Metabolomics; Tryptophan | 2018 |
8 other study(ies) available for tryptophan and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Metabolomic adaptations and correlates of survival to immune checkpoint blockade.
Topics: Adaptation, Physiological; Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Clinical Trials as Topic; Everolimus; Female; Humans; Kaplan-Meier Estimate; Kidney Neoplasms; Kynurenine; Male; Melanoma; Metabolomics; Middle Aged; Nivolumab; Programmed Cell Death 1 Receptor; Treatment Outcome; Tryptophan | 2019 |
Tryptophan 2,3-dioxygenase in tumor cells is associated with resistance to immunotherapy in renal cell carcinoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cell Line, Tumor; Chemotherapy, Adjuvant; Disease Progression; Drug Resistance, Neoplasm; Female; Humans; Immune Checkpoint Inhibitors; Immunohistochemistry; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kidney; Kidney Neoplasms; Kynurenine; Male; Middle Aged; Nephrectomy; Progression-Free Survival; Tryptophan; Tryptophan Oxygenase | 2021 |
Combination of serum histidine and plasma tryptophan as a potential biomarker to detect clear cell renal cell carcinoma.
Topics: Biomarkers, Tumor; Carcinoma, Renal Cell; Case-Control Studies; Histidine; Humans; Kidney Neoplasms; Models, Biological; Tryptophan | 2017 |
Inhibiting tryptophan metabolism enhances interferon therapy in kidney cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cell Line, Tumor; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Indoles; Interferon-alpha; Kidney Neoplasms; Mice; Mice, Inbred BALB C; Thiohydantoins; Tryptophan | 2016 |
Kidney tumor biomarkers revealed by simultaneous multiple matrix metabolomics analysis.
Topics: Animals; Biomarkers, Tumor; Carcinoma, Renal Cell; Cell Line, Tumor; Cell Proliferation; Chromatography, Liquid; Humans; Kidney Neoplasms; Mass Spectrometry; Metabolomics; Mice; Mice, Nude; PPAR alpha; Transplantation, Heterologous; Tryptophan; Tumor Escape; Validation Studies as Topic | 2012 |
Tryptophan depletion and the kinase GCN2 mediate IFN-γ-induced autophagy.
Topics: Autophagy; Carcinoma, Renal Cell; Cytokines; Epithelial Cells; Humans; Inflammation Mediators; Interferon-gamma; Kidney Neoplasms; Protein Serine-Threonine Kinases; Tryptophan; Tumor Cells, Cultured | 2012 |
A HYPERNEPHROMA ASSOCIATED WITH ELEVATED LEVELS OF BLADDER CARCINOGENS IN THE URINE: CASE REPORT.
Topics: Adenocarcinoma; Carcinogens; Carcinoma, Renal Cell; Kidney Neoplasms; Neoplasms; Nephrectomy; Pathology; Tryptophan; Urinary Bladder; Urine | 1963 |
Expression of indoleamine 2,3-dioxygenase in tumor endothelial cells correlates with long-term survival of patients with renal cell carcinoma.
Topics: Aged; Carcinoma, Renal Cell; Cell Line, Tumor; Disease Progression; Endothelial Cells; Female; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interferon-gamma; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neovascularization, Pathologic; Prognosis; Retrospective Studies; RNA, Messenger; Tryptophan | 2007 |